BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16202605)

  • 1. Cytotoxic activity of (S)-goniothalamin and analogues against human cancer cells.
    Fátima Ad; Kohn LK; Carvalho JE; Pilli RA
    Bioorg Med Chem; 2006 Feb; 14(3):622-31. PubMed ID: 16202605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of methoxylated goniothalamin, aza-goniothalamin and γ-pyrones and their in vitro evaluation against human cancer cells.
    Barcelos RC; Pastre JC; Caixeta V; Vendramini-Costa DB; de Carvalho JE; Pilli RA
    Bioorg Med Chem; 2012 Jun; 20(11):3635-51. PubMed ID: 22537680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trypanocidal activity of 5,6-dihydropyran-2-ones against free trypomastigotes forms of Trypanosoma cruzi.
    de Fátima A; Marquissolo C; de Albuquerque S; Carraro-Abrahão AA; Pilli RA
    Eur J Med Chem; 2006 Oct; 41(10):1210-3. PubMed ID: 16815596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetric total synthesis and antiproliferative activity of goniothalamin oxide isomers.
    Marquissolo C; de Fátima A; Kohn LK; Ruiz AL; de Carvalho JE; Pilli RA
    Bioorg Chem; 2009 Apr; 37(2):52-6. PubMed ID: 19185327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and cytotoxic activity of fluorinated analogues of Goniothalamus lactones. Impact of fluorine on oxidative processes.
    Dumitrescu L; Mai Huong DT; Van Hung N; Crousse B; Bonnet-Delpon D
    Eur J Med Chem; 2010 Jul; 45(7):3213-8. PubMed ID: 20392543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity of goniothalamin enantiomers in renal cancer cells: involvement of nitric oxide, apoptosis and autophagy.
    de Fátima A; Zambuzzi WF; Modolo LV; Tarsitano CA; Gadelha FR; Hyslop S; de Carvalho JE; Salgado I; Ferreira CV; Pilli RA
    Chem Biol Interact; 2008 Nov; 176(2-3):143-50. PubMed ID: 18771661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (R)-Goniothalamin: total syntheses and cytotoxic activity against cancer cell lines.
    de Fátima A; Kohn LK; Antônio MA; de Carvalho JE; Pilli RA
    Bioorg Med Chem; 2005 Apr; 13(8):2927-33. PubMed ID: 15781402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total synthesis and biological evaluation of potent analogues of dictyostatin: modification of the C2-C6 dienoate region.
    Paterson I; Gardner NM; Guzmán E; Wright AE
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6268-72. PubMed ID: 18951787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SAR studies of brasilicardin A for immunosuppressive and cytotoxic activities.
    Komatsu K; Tsuda M; Tanaka Y; Mikami Y; Kobayashi J
    Bioorg Med Chem; 2005 Mar; 13(5):1507-13. PubMed ID: 15698766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and in vitro evaluation against human cancer cells of 5-methyl-5-styryl-2,5-dihydrofuran-2-ones, a new series of goniothalamin analogues.
    Bruder M; Vendramini-Costa DB; de Carvalho JE; Pilli RA
    Bioorg Med Chem; 2013 Sep; 21(17):5107-17. PubMed ID: 23876338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spiro[(dihydropyrazin-2,5-dione)-6,3'-(2',3'-dihydrothieno[2,3-b]naphtho-4',9'-dione)]-based cytotoxic agents: structure-activity relationship studies on the substituent at N4-position of the diketopiperazine domain.
    Gomez-Monterrey I; Campiglia P; Carotenuto A; Stiuso P; Bertamino A; Sala M; Aquino C; Grieco P; Morello S; Pinto A; Ianelli P; Novellino E
    J Med Chem; 2008 May; 51(10):2924-32. PubMed ID: 18429610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor benzothiazoles. 26.(1) 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines.
    Mortimer CG; Wells G; Crochard JP; Stone EL; Bradshaw TD; Stevens MF; Westwell AD
    J Med Chem; 2006 Jan; 49(1):179-85. PubMed ID: 16392802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive study of sansalvamide A derivatives and their structure-activity relationships against drug-resistant colon cancer cell lines.
    Otrubova K; Lushington G; Vander Velde D; McGuire KL; McAlpine SR
    J Med Chem; 2008 Feb; 51(3):530-44. PubMed ID: 18186604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor agents 260. New desmosdumotin B analogues with improved in vitro anticancer activity.
    Nakagawa-Goto K; Bastow KF; Chen TH; Morris-Natschke SL; Lee KH
    J Med Chem; 2008 Jun; 51(11):3297-303. PubMed ID: 18473435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and cytotoxic evaluation of novel spirohydantoin derivatives of the dihydrothieno[2,3-b]naphtho-4,9-dione system.
    Gomez-Monterrey I; Santelli G; Campiglia P; Califano D; Falasconi F; Pisano C; Vesci L; Lama T; Grieco P; Novellino E
    J Med Chem; 2005 Feb; 48(4):1152-7. PubMed ID: 15715481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and cytotoxic evaluation of a new series of 3-substituted spiro[(dihydropyrazine-2,5-dione)-6,3'-(2',3'-dihydrothieno[2,3-b]naphtho-4',9'-dione)] derivatives.
    Gomez-Monterrey I; Campiglia P; Carotenuto A; Califano D; Pisano C; Vesci L; Lama T; Bertamino A; Sala M; di Bosco AM; Grieco P; Novellino E
    J Med Chem; 2007 Apr; 50(8):1787-98. PubMed ID: 17375902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in Vitro cytotoxic activities of 2-alkyl-2,3-dihydro-1H-2,6-diazacyclopenta[b]anthracene-5,10-diones.
    Kwak JH; Namgoong K; Jung JK; Han SB; Cho J; Kim HM; Park SG; Lee K; Kang JS; Lee H
    Arch Pharm Res; 2010 May; 33(5):663-7. PubMed ID: 20512462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and cytotoxic activities of 2-alkyl-2,3-dihydro-1H-2,6,9-triazacyclopenta[b]anthracene-5,10-diones.
    Kwak JH; Namgoong K; Jung JK; Cho J; Kim HM; Park SG; Yoo YA; Kwon JH; Lee H
    Arch Pharm Res; 2008 Aug; 31(8):995-8. PubMed ID: 18787787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-Bicycloaryl substituted (S)- and (R)-5,6-dihydro-2H-pyran-2-ones: asymmetric synthesis, and anti-proliferative properties.
    Kasaplar P; Yilmazer O; Cağir A
    Bioorg Med Chem; 2009 Jan; 17(1):311-8. PubMed ID: 19022676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of antineoplastic ring-substituted ether phospholipid derivatives.
    Papazafiri P; Avlonitis N; Angelou P; Calogeropoulou T; Koufaki M; Scoulica E; Fragiadaki I
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):261-70. PubMed ID: 15856232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.